Kieger Sustainable Healthcare Fund Class B USD Accumulating

Reference Data

ISIN LU2488092995
Valor Number 119403768
Bloomberg Global ID
Fund Name Kieger Sustainable Healthcare Fund Class B USD Accumulating
Fund Provider Kieger AG Kieger AG
Limmatstrasse 264, CH-8005 Zürich
Phone: +41 44 444 18 44
Web: https://kieger.com/
E-Mail: info@kieger.com
Fund Provider Kieger AG
Representative in Switzerland ACOLIN Fund Services AG
Zürich
Phone: +41 44 396 96 96
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager.
Peculiarities

Fund Prices

Current Price * 105.36 USD 18.08.2025
Previous Price * 103.59 USD 14.08.2025
52 Week High * 121.94 USD 30.08.2024
52 Week Low * 100.18 USD 07.08.2025
NAV * 105.36 USD 18.08.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 213,304,745
Unit/Share Assets *** 1,129,771
Trading Information SIX

Performance

YTD Performance -0.25% 31.12.2024
18.08.2025
YTD Performance (in CHF) -11.29% 31.12.2024
18.08.2025
1 month +1.36% 18.07.2025
18.08.2025
3 months -0.69% 19.05.2025
18.08.2025
6 months -6.12% 18.02.2025
18.08.2025
1 year -11.61% 19.08.2024
18.08.2025
2 years +5.72% 18.08.2023
18.08.2025
3 years +5.36% 05.07.2023
18.08.2025
5 years - -

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Abbott Laboratories 5.91%
Eli Lilly and Co 5.61%
AstraZeneca PLC 5.57%
Novartis AG Registered Shares 5.48%
Roche Holding AG 4.86%
Vertex Pharmaceuticals Inc 4.12%
Boston Scientific Corp 3.96%
Intuitive Surgical Inc 3.76%
Novo Nordisk AS Class B 3.63%
UnitedHealth Group Inc 3.47%
Last data update 31.05.2025

Cost / Risk

TER *** 0.99%
TER date *** 30.09.2023
Performance Fee ***
PTR
Max. Management Fee *** 0.85%
Ongoing Charges *** 0.99%
SRRI ***
SRRI date *** 31.07.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)